Reports on the development of genetic screening tests that detect a rare, lethal form of thyroid cancer in the preclinical state and which permits early treatment in children predisposed to the disease. Discovery of mutations for multiple endocrine neoplasia type 2A (MEN 2A) in the ret proto-oncogene on chromosome 10; Use of a genetic assay based on polymerase chain reaction (PCR).